<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPLs) are associated with <z:mp ids='MP_0005048'>thrombosis</z:mp>, but the mechanisms of this thrombotic tendency are unknown </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 56 patients 612 with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> [SLE] and aPLs and previous <z:mp ids='MP_0005048'>thrombosis</z:mp>, 12 with SLE and aPLs but no <z:mp ids='MP_0005048'>thrombosis</z:mp>, 15 with SLE without aPLs or <z:mp ids='MP_0005048'>thrombosis</z:mp>, 11 with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> with <z:mp ids='MP_0005048'>thrombosis</z:mp>, and 6 asymptomatic subjects with aPLs) to investigate the ability of aPLs to induce tissue factor (TF) expression on human <z:mpath ids='MPATH_458'>normal</z:mpath> monocytes </plain></SENT>
<SENT sid="2" pm="."><plain>A double direct immunofluorescence technique (anti-CD14 and anti-TF) was used, and procoagulant activity in viable and disrupted cells was measured after plasma incubation for 6 hours at 37 degrees C with <z:mpath ids='MPATH_458'>normal</z:mpath> mononuclear cells </plain></SENT>
<SENT sid="3" pm="."><plain>Hemostasis regulatory proteins, prothrombin fragment 1 + 2, and thrombin-antithrombin III complex levels were determined </plain></SENT>
<SENT sid="4" pm="."><plain>Increased TF expression and procoagulant activity were observed using plasma samples from SLE patients with aPLs and <z:mp ids='MP_0005048'>thrombosis</z:mp> (P &lt; .01) and from <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> patients (P &lt; .01) but not from patients with SLE and aPLs but no <z:mp ids='MP_0005048'>thrombosis</z:mp>, patients with SLE without aPLs, or asymptomatic patients with aPLs </plain></SENT>
<SENT sid="5" pm="."><plain>Purified aPL immunoglobulins from one <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and two SLE patients added to <z:mpath ids='MPATH_458'>normal</z:mpath> plasma showed a significant increase in both TF expression and procoagulant activity (P &lt; .05) compared with purified aPL from two SLE patients without <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The addition of nonspecific IgG from three SLE patients without aPLs and from three control subjects did not increase TF expression </plain></SENT>
<SENT sid="7" pm="."><plain>Low free protein S was seen in eight patients </plain></SENT>
<SENT sid="8" pm="."><plain>Increased TF expression and low free protein S correlated with <z:mp ids='MP_0005048'>thrombosis</z:mp> (P &lt; .01) and with higher prothrombin fragment 1 + 2 and thrombin-antithrombin III values (P &lt; .01) </plain></SENT>
<SENT sid="9" pm="."><plain>These observations may contribute to a further understanding of the thrombotic risk in aPL patients </plain></SENT>
</text></document>